The analysis reports a 20 percent to 40 percent replacement of primary lumbar fusion surgeries with decompression and interlaminar stabilization device could reduce costs $0.25 to $0.49 per member per month.
“All stakeholders, including patients, physicians, payers, providers and policy-makers, are critically focused on cost-effective healthcare therapeutic solutions which provide sustainable and durable treatment effects to a large population,” said Paradigm Spine CEO and Chairman Marc Viscogliosi. “The independent analysis, combined with Paradigm Spine’s long term clinical data publications, continues to support technologies such as coflex interlaminar stabilization providing improved patient outcomes and cost savings to the health system.”
Miliman does not intend to endorse any product or organization with the paper.
More articles on orthopedic devices:
42 spine, orthopedic devices receive FDA 510(k) clearance in September
Exactech Q3 revenue drops 3%: 10 key notes
North America dominates spine surgery devices market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
